Helen M. Thackray

Insider Reports History

Location
Gaithersburg, MD
Signature
/s/ Alane P. Barnes, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Helen M. Thackray:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Common Stock 377,318 $2,829,885 $7.50 31 Mar 2025 Direct
ImmunoGen, Inc. Director Common Stock 0 $0 $29.30 12 Feb 2024 Direct
ImmunoGen, Inc. Director Deferred Share Unit 0 $0 $29.30 12 Feb 2024 Direct
ImmunoGen, Inc. Director Restricted Stock Unit 0 $0 $29.30 12 Feb 2024 Direct
BIOCRYST PHARMACEUTICALS INC Chief R&D Officer Emp. Stock Option (Right to Buy) 260,950 19 Dec 2024 Direct
ImmunoGen, Inc. Director Stock Option (Right to Buy) 0 12 Feb 2024 Direct

Insider Reports Filed by Helen M. Thackray

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCRX BIOCRYST PHARMACEUTICALS INC 31 Mar 2025 1 -$56,438 4 Chief R&D Officer 02 Apr 2025, 16:18
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2024 3 -$45,049 4 Chief R&D Officer 23 Dec 2024, 16:15
BCRX BIOCRYST PHARMACEUTICALS INC 14 Dec 2024 1 -$53,840 4 Chief R&D Officer 17 Dec 2024, 16:03
BCRX BIOCRYST PHARMACEUTICALS INC 14 May 2024 1 +$175,800 4 Chief R&D Officer 15 May 2024, 07:17
BCRX BIOCRYST PHARMACEUTICALS INC 31 Mar 2024 1 -$38,227 4 Chief R&D Officer 02 Apr 2024, 16:21
/report/000110465924014717-thackray-helen-m-2024-02-12 ImmunoGen, Inc. 12 Feb 2024 6 $0 4 Director 12 Feb 2024, 16:47
/report/000141588924000372-thackray-helen-m-2023-12-29 ImmunoGen, Inc. 29 Dec 2023 1 +$7,472 4 Director 03 Jan 2024, 17:42
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2023 1 -$33,759 4 Chief R&D Officer 20 Dec 2023, 16:42
BCRX BIOCRYST PHARMACEUTICALS INC 14 Dec 2023 3 -$19,489 4 Chief R&D Officer 18 Dec 2023, 16:47
/report/000141588923013759-thackray-helen-m-2023-09-29 ImmunoGen, Inc. 29 Sep 2023 1 +$7,491 4 Director 02 Oct 2023, 17:07
/report/000141588923010819-thackray-helen-m-2023-06-30 ImmunoGen, Inc. 30 Jun 2023 1 +$7,491 4 Director 05 Jul 2023, 17:52
/report/000141588923009953-thackray-helen-m-2023-06-14 ImmunoGen, Inc. 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 16:50
BCRX BIOCRYST PHARMACEUTICALS INC 03 Apr 2023 1 -$58,030 4 Chief R&D Officer 05 Apr 2023, 16:33
/report/000141588923006063-thackray-helen-m-2023-03-31 ImmunoGen, Inc. 31 Mar 2023 1 +$7,500 4 Director 04 Apr 2023, 16:54
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2022 2 $0 4 Chief R&D Officer 21 Dec 2022, 15:41
BCRX BIOCRYST PHARMACEUTICALS INC 15 Dec 2022 1 -$34,031 4 Chief R&D Officer 19 Dec 2022, 15:58
/report/000141588922006706-thackray-helen-m-2022-06-15 ImmunoGen, Inc. 15 Jun 2022 2 +$108,062 4 Director 17 Jun 2022, 16:09
BCRX BIOCRYST PHARMACEUTICALS INC 01 Apr 2022 1 -$123,120 4 Chief R&D Officer 04 Apr 2022, 16:32
BCRX BIOCRYST PHARMACEUTICALS INC 14 Dec 2021 2 $0 4 Chief R&D Officer 16 Dec 2021, 16:06
/report/000117911021008903-thackray-helen-m-2021-09-22 ImmunoGen, Inc. 22 Sep 2021 2 +$262,680 4 Director 23 Sep 2021, 16:35
/report/000117911021008902-thackray-helen-m-2021-09-22 ImmunoGen, Inc. 22 Sep 2021 0 $0 3 Director 23 Sep 2021, 16:34
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .